Best Practices : Fetal Alcohol Syndrome/Fetal Alcohol Effects and the Effects of Other Substance Use During Pregnancy

Section I: Project Brackground and Description

• Acknowledgments
• 1. Introduction
  • 1.1 Project Context and Purpose
  • 1.2 Methodology
  • 1.2.1 Scope of the Search
  • 1.2.2 Development of Best Practice Statements
  • 1.3 Key Definitions
• 2. Epidemiology
• 2.1 Epidemiology of Alcohol Use and Pregnancy
• 2.1.1 Alcohol Use by Women of Child-bearing Age and Pregnant Women
• 2.1.2 Characteristics of Women at-risk of Having a Child Affected by Alcohol Use During Pregnancy
• 2.1.3 Characteristics of Women Who Have Given Birth to a Child Affected by FAS or Related Effects
• 2.2 Epidemiology of Other Substance Use and Pregnancy
• 2.2.1 Characteristics of Women at-risk of Having a Child Affected by Other Substance Use During Pregnancy
• 2.3 Summary

Section II: Results

• 3. Primary Prevention
• 3.1 Population Health Promotion
• 3.2 Alcohol Control Measures
• 3.3 Public Awareness Approaches
• 3.4 Multi-component Awareness Strategies
• 3.5 Other Measures
• 3.6 Summary
• 3.7 Best Practice Statements
• 4. Secondary Prevention
• 4.1 Introduction
• 4.2 Barriers to Identification and Intervention
• 4.3 Outreach Activities
• 4.4 Identifying Women With Substance Use Problems
• 4.5 Brief Interventions
• 4.6 Professional Development Issues
• 4.7 Summary
• 4.8 Best Practice Statements
• 5. Tertiary Prevention
• 5.1 Introduction
• 5.2 Barriers of Acessing Care
• 5.3 Need for Prenatal Medical and Social Attention
• 5.4 Management of Withdrawal
• 5.5 Effectiveness of Substance Abuse Treatment for Women
• 5.6 Effectiveness of Treatment for Pregnant Women with Substance Use Problems
• 5.6.1 Respectful Service Philosophy
• 5.6.2 Providing Comprehensive and Practical Care
• 5.6.3 Interagency Collaboration and Coordination of Services
• 5.6.4 A Broad and Flexible Continuum of Substance Abuse Services
• 5.7 Seattle Birth to Three Program
• 5.8 Other Treatment Modalities
• 5.8.1 Contingency Management
• 5.8.2 Methadone Maintenance Treatment
• 5.8.3 Culturally Appropriate Treatment for Aboriginal Women
• 5.9 Cost Effectiveness of Treatment
• 5.10 Policy and Legal Issues
• 5.11 Summary
• 5.12 Best Practice Statements
• 6. Identification of FAS and Related Effects
• 6.1 Prevalence of FAS and Related Effects
• 6.2 Guidelines for Diagnosis of FAS and Related Effects
• 6.3 Identification and Diagnosis Through the Life-Span
• 6.4 Issues in Identification and Diagnosis
• 6.5 Canadian Issues in Identification and Diagnosis
• 6.6 Organizing for Identification and Diagnosis
• 6.7 Identification of Fetal Drug Exposure
• 6.7.1 Cannabis
• 6.7.2 Opiates
• 6.7.3 Cocaine
• 6.7.4 Inhalants
• 6.8 Professional Development Issues
• 6.9 Summary
• 6.10 Best Practice Statements
• 7. Interventions for Persons Affected by Prenatal Substance Use
• 7.1 Infancy and Early Childhood Interventions
• 7.1.1 Medical Issues
• 7.1.2 Family Issues
• 7.1.3 Psychoeducational Issues
• 7.1.4 Summary
• 7.1.5 Best Practice Statements
• 7.2 Later Childhood Interventions
• 7.2.1 Medical Issues
• 7.2.2 Family and Social Issues
• 7.2.3 Psychoeducational Issues
• 7.2.4 Summary
• 7.2.5 Best Practice Statements
• 7.3 Adolescent Interventions
• 7.3.1 Medical Issues
• 7.3.2 Psychoeducational and Social Issues
• 7.3.3 Correcional Issues
• 7.3.4 Summary
• 7.3.5 Best Practice Statements
• 7.4 Adult Interventions
• 7.4.1 Medical Issues
• 7.4.2 Psychoeducational and Social Issues
• 7.4.3 Correcional Issues
• 7.4.4 Summary
• 7.4.5 Best Practice Statements
• 7.5 Interventions for Children Affected by Other Drug Use During Pregnancy
• 7.5.1 Early Childhood
• 7.5.2 Later Childhood
• 7.5.3 Summary
• 7.5.4 Best Practice Statements
• 8. Summary of Best Practice Statements

Steering Committee Members

Bibliography